SOURCE: Pharma-Bio Serv Inc.

Pharma-Bio Serv Inc.

August 25, 2014 08:00 ET

Pharma-Bio Serv to Present at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014

DORADO, PUERTO RICO--(Marketwired - Aug 25, 2014) - Pharma-Bio Serv. (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, announced today that the Company will be a featured presenter at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014 at the New York Palace Hotel in New York City.

Pharma-Bio Serv will be presenting at 10:50 am, Wednesday, September 10th in the Stanford Salon (4th Floor), where it will discuss the company's business model and growth strategy.

The Conference will be held September 9 and 10, 2014 and will include corporate presentations and Q&A sessions, investor one-on-one meetings and daily networking opportunities. For more information or to register for the conference, please visit the conference website at http://www.rodm.com. Once your registration is confirmed, you may log into the conference website to request a one-on-one meeting with the Company.

About Pharma-Bio Serv Inc.

Pharma-Bio Serv is a compliance, project management and technology transfer support consulting firm, headquartered in Puerto Rico, with operations in the U.S., Ireland and Spain. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance related services with integrated portfolio services including microbiological and chemical testing services for clients in the Pharmaceutical, Biotechnology, Chemical, Medical Device, Cosmetic, Food and Allied Products industries, at its laboratory testing facility in Puerto Rico. Services also include "Integratek," an information technology consulting practice, and "Pharma Serv Academy" a division that provides technical and regulatory standards seminars/training conducted by industry experts. The Company's global team includes more than 300 leading engineering and life science professionals, quality assurance managers and directors.

Forward Looking Statements

This news release and the presentation contain "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this news release. Although Pharma-Bio Serv's management believes these expectations, estimates, or projections to be reasonable as of the date of this news release, forward-looking statements are inherently subject to significant business risks, economic and competitive uncertainties, or other contingencies, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of Pharma-Bio Serv's Annual Report on Form 10-K for the year ended October 31, 2013 and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.

Contact Information